Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Wellbeing Digital Sciences Inc (OP: KONEF ) N/A UNCHANGED Last Price Updated: 3:57 PM EST, Mar 6, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Wellbeing Digital Sciences Inc < Previous 1 2 Next > World's Largest Psychedelics Conference Sheds Light On Alternative Mental Health Therapies, Boasts 12K Attendees June 26, 2023 The Multidisciplinary Association for Psychedelic Studies (MAPS) sponsored a Psychedelic Science conference in Denver last week, which gathered over 12,000 people from the entire psy Via Benzinga Psyched: Next-Gen Compounds For Depression, Congress, Rescheduling, Benzinga Psychedelics Conference & More March 13, 2023 Major Depressive Disorder: Small Pharma’s Phase 2 DMT Trial, BetterLife’s Preclinical LSD Trial Via Benzinga Another Company Approved To Begin Production Of Psychedelics Under Canadian Dealers License March 09, 2023 A Contract Research Organization (CRO) and a wholly-owned subsidiary of Wellbeing Digital Sciences Inc. Via Benzinga Who's Who At The Benzinga Psychedelics Capital Conference? Check Out These CEOs & Meet Them In Person March 08, 2023 This year’s edition of the Benzinga Psychedelics Capital Conference, THE place to be for those interested or already involved in the space, will take place on April 13, following our established... Via Benzinga Psyched: Four New States With Reform Bills, Psilocybin For Genetic Disorders And Functional Neurological Disorder, Struggle For Access & More February 21, 2023 Psychedelics States Reform: Utah, Iowa, Missouri and Oklahoma’s New Bills; Hawaii, Arizona and Washington's Green Lights, New Hampshire's Setback Earlier this week, three bills were introduced and... Via Benzinga Wellbeing Digital Net Loss Continues To Grow: Q2 Reaches $5.15M, Up By 552% YoY March 18, 2022 Wellbeing Digital Sciences Inc. (OTCQB:KONEF Via Benzinga Health Canada Grants Exemption: Phase 2 Trial On Psilocybin For Genetic Disorder February 14, 2023 Wellbeing Digital (OTC: KONEF) subsidiary KGK Sciences will advance with the first-ever Phase 2a clinical trial assessing repetitive, oral microdose psilocybin therapy for Fragile X Syndrome (FXS), a... Via Benzinga Women's Footprint In Psychedelics Is Undeniable, Benzinga's Psychedelics Advisory Council's Six New Trailblazers January 30, 2023 In its capacity as a financial news and media outlet, Benzinga has added six new members to its Psychedelics Advisory Council. Via Benzinga First-Ever Clinical Trial On Magic Mushroom Therapy For Autism's Genetic Cause Receives Approval December 27, 2022 The partnership leading the way on psilocybin therapy for Fragile X Syndrome (FXS), the major genetic cause of Autism Spectrum Disorder (ASD), has received approval from Health Canada in the form of a... Via Benzinga Psyched: Fed Guidelines And Research Production Quotas, Protests In Canada, Cal's Decrim Project December 06, 2022 Psychedelic Research & Fed Funding By The National Institute Of Mental Health The National Institute of Mental Health (NIMH) named the types of psychedelics studies to which it would grant funds and... Via Benzinga Psychedelic Partnership To Test Psilocybin For FXS In First Phase 2 Clinical Trial November 30, 2022 Psychedelics biotechs Nova Mentis Life Science Corp. (OTCQB: NMLSF) and Wellbeing Digital Sciences Inc. (OTC: KONEF)’s subsidiary KGK Sciences Inc. Via Benzinga Psyched: Musk's Empathy Tweets, Psychedelics In Congress, Oregon's Opt-Outs, MAPS' MDMA Trial And More November 21, 2022 Elon Musk Joins Twitter Conversation Around Psychedelics: A Debate On Empathy Via Benzinga Psychedelics For FXS Symptoms: New Research Contract For Upcoming Phase 2 Clinical Trial November 17, 2022 Psychedelics company Wellbeing Digital Sciences Inc. (OTC: KONEF)’s subsidiary KGK Science Inc. has entered into a research services agreement with Canadian-based biotech Nova Mentis Life Science... Via Benzinga Successful Study On Transdermal CBD & THC Delivery Presents Benefits For Treating Chronic Conditions November 15, 2022 Wellbeing Digital Sciences Inc. (NEO: MEDI) (OTC: KONEF) (FRA: SQ2), an evidence-based mental healthcare company announced that its wholl Via Benzinga Psyched: Top Psychedelics Execs., 50% Of Americans Support Medical Psychedelics, Cary Grant's LSD Therapy & More November 01, 2022 15 Global Psychedelics Executives To Keep An Eye On In 2022 Via Benzinga Pathway Health To Acquire IRP Health From Wellbeing Digital Sciences October 27, 2022 Wellbeing Digital Sciences Inc. Via Benzinga Psyched: CA's Psychedelic-Assisted Treatments, Ketamine Therapy, Near-Death Experience And More October 07, 2022 Alberta Becomes The First Canadian Province To Regulate Psychedelics-Assisted Therapy Via Benzinga Ketamine Therapy At Your Doorstep, Growing Number Of Clinics Offer This Treatment Option October 05, 2022 Being the sole psychedelic legally available as medicine, ketamine-assisted therapy services are expanding at a rapid pace across the U.S. Via Benzinga Wellbeing Digital Reports 4Q Finances, 'Three Key Pillars' Stay Strong September 16, 2022 Wellbeing Digital Sciences Inc. (OTC: KONEF) filed its financial results for the quarter ended July 31, 2022 and provided some insight on their most recent businesses. Numbers for the selected period... Via Benzinga World Class Leaders In Psychedelics Form Benzinga's Psychedelic Advisory Council—Get To Know Them August 30, 2022 The Benzinga Psychedelics Advisory Council was introduced in March of 2022 with the sustained goal of better informing investors and general audience about the psychedelics financial and business... Via Benzinga KGK Sciences And Halucenex Sign Contract For Phase II Clinical Trial On Psilocybin For PTSD July 21, 2022 KGK Sciences Inc., a subsidiary company of psychedelics healthcare researcher and provider Wellbeing Digital Sciences Inc. Via Benzinga Wellbeing Digital Introduces Women In Psychedelics, A Network For Female Minds In Psychedelics July 18, 2022 Mental healthcare company Wellbeing Digital Sciences Inc. (OTC: KONEF) and its subsidiary KGK Science Inc. are the founding sponsors of the Women in Psychedelics Network, also known as “WIP.” Via Benzinga Mind Medicine, Small Pharma Among Top Psychedelic Movers Of Today March 15, 2022 GAINERS: Mind Medicine (NASDAQ: Via Benzinga Wellbeing Digital, Small Pharma Among Top Psychedelic Movers Of Today March 14, 2022 GAINERS: Wellbeing Digital (OTC: Via Benzinga Psychedelic Stock Gainers And Losers From March 7, 2022 March 07, 2022 GAINERS: GH Research (NASDAQ: Via Benzinga Psychedelic Stock Gainers And Losers From March 4, 2022 March 04, 2022 GAINERS: Wellbeing Digital (OTC: Via Benzinga Psychedelic Stock Gainers And Losers From March 1, 2022 March 01, 2022 GAINERS: Cybin (AMEX: Via Benzinga Psychedelic Stock Gainers And Losers From February 28, 2022 February 28, 2022 GAINERS: Wellbeing Digital (OTC: Via Benzinga Psychedelic Stock Gainers And Losers From February 14, 2022 February 14, 2022 GAINERS: Wellbeing Digital (OTC: Via Benzinga Wellbeing Digital Sciences' Integrated Approach Aims To Capture Emerging Mental Health Tech And Psychedelics Market February 08, 2022 Image provided by Pexels This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice. Via Benzinga < Previous 1 2 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.